Repository logo
 

Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Type 2 diabetes (T2D) is a prevalent disease arising from complex molecular mechanisms. Here we leverage T2D genetic associations to identify causal molecular mechanisms in an ancestry-aware and tissue-aware manner. Using two-sample Mendelian randomization corroborated by colocalization across four global ancestries, we analyse 20,307 gene and 1,630 protein expression levels using blood-derived cis-quantitative trait loci (QTLs). We detect causal effects of genetically predicted levels of 335 genes and 46 proteins on T2D risk, with 16.4% and 50% replication in independent cohorts, respectively. Using gene expression cis-QTLs derived from seven T2D-relevant tissues, we identify causal links between the expression of 676 genes and T2D risk, refining known associations such as BAK1 and describing additional ones like CPXM1. Causal effects are mostly shared across ancestries but are highly heterogeneous across tissues. Our findings provide insights into cross-ancestry and tissue-informed multi-omics causal inference approaches and demonstrate their power in uncovering molecular processes driving T2D.

Description

Funder: European Union’s Horizon 2020 research and innovation programme - Grant Agreement No 101017802


Funder: National Institutes of Health (R01DK118011 and R01DK136671)


Funder: Versus Arthritis (21754) NIHR Manchester Biomedical Research Centre (NIHR203308)

Journal Title

Nat Metab

Conference Name

Journal ISSN

2522-5812
2522-5812

Volume Title

8

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Japan Society for the Promotion of Science London (JSPS London) (202460267)
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) (AD6-200177)
American Diabetes Association (ADA) (11-23-PDF-35, 11-22-JDFPM-06)
RCUK | MRC | Medical Research Foundation (MR/W029626/1)